- Home
- BY vs NVCR Comparison
BY vs NVCR Comparison
Compare BY & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BY
- NVCR
- Stock Information
- Founded
- BY 1914
- NVCR 2000
- Country
- BY United States
- NVCR Switzerland
- Employees
- BY N/A
- NVCR N/A
- Industry
- BY Major Banks
- NVCR Medical/Dental Instruments
- Sector
- BY Finance
- NVCR Health Care
- Exchange
- BY Nasdaq
- NVCR Nasdaq
- Market Cap
- BY 1.3B
- NVCR 1.4B
- IPO Year
- BY 2017
- NVCR 2015
- Fundamental
- Price
- BY $27.26
- NVCR $14.18
- Analyst Decision
- BY Hold
- NVCR Buy
- Analyst Count
- BY 3
- NVCR 7
- Target Price
- BY $33.00
- NVCR $28.79
- AVG Volume (30 Days)
- BY 234.9K
- NVCR 1.8M
- Earning Date
- BY 10-23-2025
- NVCR 10-30-2025
- Dividend Yield
- BY 1.45%
- NVCR N/A
- EPS Growth
- BY N/A
- NVCR N/A
- EPS
- BY 2.68
- NVCR N/A
- Revenue
- BY $384,591,000.00
- NVCR $630,160,000.00
- Revenue This Year
- BY $18.69
- NVCR $6.68
- Revenue Next Year
- BY $3.10
- NVCR $7.01
- P/E Ratio
- BY $10.27
- NVCR N/A
- Revenue Growth
- BY 2.48
- NVCR 14.58
- 52 Week Low
- BY $22.63
- NVCR $10.87
- 52 Week High
- BY $32.89
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- BY 44.49
- NVCR 57.02
- Support Level
- BY $26.30
- NVCR $12.84
- Resistance Level
- BY $28.38
- NVCR $14.69
- Average True Range (ATR)
- BY 0.60
- NVCR 0.63
- MACD
- BY -0.10
- NVCR -0.03
- Stochastic Oscillator
- BY 39.41
- NVCR 66.67
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.